Indianapolis Business Journal

APRIL 22-28, 2022

The global market for nuclear medicine is expected to quintuple in about a decade, and a large slice of that growth is expected to occur in the Indianapolis area. John Russell reports that Telix Pharmaceuticals, which has developed an imaging agent that makes cancer cells light up in scans, is having a breakout moment. Also in this week’s issue, Susan Orr unravels the story of a Fishers man facing a tangle of legal issues related to accusations he was involved in the nationwide sale of more than $230 million in questionable financial products. And Daniel Bradley reports that interest is accelerating in the slow-to-develop Zionsville’s Creekside Corporate Park now that construction of the new Rahal Letterman Lanigan Racing team headquarters is well under way.

Front PageBack to Top

Top StoriesBack to Top

FocusBack to Top

OpinionBack to Top

Katie Culp: Approach new innovation districts with optimism

Under this new system, the state, a county, a city, or a town, is empowered to create districts which capture new property taxes, including TIF, but also capture incremental sales and income taxes. This ability creates the potential to generate the most lucrative economic value of any state or local incentive program in Indiana.

Read More

In BriefBack to Top